NURS 6521: Advanced Pharmacology | Week 2 Assignment Brief
Week 2: Cardiovascular System Alterations
Alterations of the cardiovascular system can cause serious adverse events and may lead to death when not treated in a timely and safe manner. Recognizing these swift, life-threatening changes requires the keen eye and swift knowledge that advanced practice nursing demands. Unfortunately, many patients with cardiovascular disorders are unaware until complications appear. In clinical settings, patients often present with symptoms of several cardiovascular disorders, making it essential for you, as the advanced practice nurse, to be able to recognize these symptoms and recommend appropriate drug treatment options. Knowing how to differentiate between overlapping symptoms is the hallmark of expert clinical practice.
This week, you examine the impact of patient factors that may lead to changes in pharmacokinetic and pharmacodynamic processes on patient drug therapy for cardiovascular disorders. Remember, tailoring a patient’s prescription based on their unique biological makeup moves us closer to truly personalized medicine. You also explore ways to improve drug therapy plans for cardiovascular disorders based on patient factors and overall health needs.
Learning Objectives
Students will:
- Analyze the influence of patient factors on pharmacokinetic and pharmacodynamic processes
- Analyze the impact of changes in pharmacokinetic and pharmacodynamic processes on patient drug therapies
- Evaluate drug therapy plans for cardiovascular disorders
Learning Resources
Required Readings (click to expand/reduce)
Required Media (click to expand/reduce)
Struggling with a similar assignment to Advanced Practice Nurse Strategies for Optimizing Cardiovascular Drug Therapy Based on Patient Pharmacokinetics?
Our qualified academic writers — all holding Masters or PhD degrees — write fully original papers tailored to your rubric, citation style, and deadline. Rated 4.9/5 by thousands of students. Free Turnitin plagiarism report included.
Get Expert Help →Assignment: Pharmacotherapy for Cardiovascular Disorders
…heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smokeβsome of the leading risk factors for heart diseaseβ¦ βMurphy et al., 2018 Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today. Embracing these newer, effective therapies means we can profoundly impact public health outcomes. Photo Credit: Getty Images/Science Photo Library RF
As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors. Your careful review of these processes is the key to minimizing adverse drug reactions and ensuring patient trust.
Reference: Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db328.htm
To Prepare
- Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
- Review the case study assigned by your Instructor for this Assignment.
- Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
- Reflect on how the factor you selected might influence the patientβs pharmacokinetic and pharmacodynamic processes.
- Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patientβs recommended drug therapy.
- Think about how you might improve the patientβs drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
By Day 7 of Week 2
Write a 2- to 3-page paper that addresses the following:
Can someone write my paper professionally and confidentially?
Yes — My Homework Ace Tutors connects you with expert human writers in your subject area. Every paper is written from scratch (zero AI), checked for plagiarism, formatted to your specifications, and delivered before your deadline — 100% confidentially. Free revisions for 14 days.
🖉 Start My Order →- Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
- Describe how changes in the processes might impact the patientβs recommended drug therapy. Be specific and provide examples.
- Explain how you might improve the patientβs drug therapy plan and explain why you would make these recommended improvements.
Optimizing cardiovascular pharmacotherapy involves rigorous application of precision medicine principles, demanding deep expertise in patient-specific genetic markers and lifestyle interactions. This focus on personalized medicine is essential for mitigating risk and maximizing therapeutic efficacy in advanced practice.
-
Using your course materials/resources: Using your course materials, explain how patient factors impact cardiovascular drug metabolism and subsequent therapy recommendations.
-
I need help with: I need help with advanced pharmacology assignment. Analyze patient factors, PK/PD, and revise drug therapy for a cardiovascular patient case.
References
The following credible, peer-reviewed references align with the analysis of patient factors (genetics, age, ethnicity) and their influence on cardiovascular pharmacotherapy:
Save 25% on your first order today
Use code BISHOPS at checkout. Our writers deliver AI-free, plagiarism-free papers — from essays to full dissertations — with deadlines from 3 hours. Money-back guarantee included.
🏢 Claim 25% Off →Johnson, J. A., & OβMara, N. (2021). Racial and ethnic differences in cardiovascular drug response: A review of genetic and environmental influences. Current Cardiology Reports, 23(7), 89.
Califf, R. M., & Krumholz, H. M. (2024). Leveraging artificial intelligence and clinical informatics for personalized cardiovascular medicine. Circulation: Cardiovascular Quality and Outcomes, 17(1), e009489.
Shrimpton, J. R., et al. (2023). Pharmacogenetics in cardiovascular disease: A practical guide for clinicians. Journal of the American Heart Association, 12(15), e029402.
Veltri, K., & Zaza, A. (2020). Pharmacokinetics and pharmacodynamics in the elderly: The influence of aging on drug therapy. Clinical Geriatrics, 28(2), 42-50.